Laddar populära aktier...
Etteplan’s Q3 was weak as was expected after the two profit warnings the company gave prior to the report.
The weakness of Etteplan’s Q3 came as a no surprise as the company released two profit warnings before the Q3 print.
Etteplan issued its second profit warning of the fiscal year prior to the Q3 report, citing ongoing weak market conditions and significant n...
Etteplan lowered its guidance as the market conditions have remained weak.
Etteplan's Q2 fell short of our estimates due to continued low customer activity.
Etteplan's Q2 results missed our estimates across the board.
Etteplan publishes its Q2/24 figures on 8th of August.
We expect the slow market to continue to impact Etteplan in 2024, while acquisitions support net sales growth.
Etteplan was able to improve its profitability during the first quarter as was expected.
Etteplan's Q1 results were largely as expected, with slight earnings miss vs.
Etteplan publishes its Q1 results on 8th of May. We expect year-on-year revenue growth boosted by acquisitions while profitability improveme...
The outlook for 2024 looks brighter after the tough 2023.
Etteplan's Q4 results were as expected, following the preliminary numbers released with January's profit warning.
Etteplan gave a profit warning as its EBIT fell short of expectations in Q4.
Etteplan reported Q3 figures that were below our estimates.
Etteplan’s sales and EBIT for Q3 were lower than expected at EUR 80.
Etteplan reports Q3 results on October 31st. We anticipate a slower quarter due to the prevailing market conditions and seasonality.
Etteplan issued a profit warning and lowered its guidance for FY 2023.
Etteplan reported Q2 results that were below our estimates.
Etteplan’s sales and EBIT from business operations were at EUR 89.
Etteplan’s continued good performance in Q1 was overshadowed by significant non-recurring items.
Etteplan's net sales in Q1 amounted to EUR 95.0m, slightly above our and consensus estimates (EUR 92.
Despite a below expectations Q4, at least partly due to increased sickness-related absences, we see slightly improving expectations for 2023...
Etteplan's net sales in Q4 amounted to EUR 91.0m, below our estimates and below consensus (EUR 99.
Etteplan reports its Q4 results on February 17th. Sights are already set on the outlook for 2023, with our expectations being on a notable y...
We terminate commissioned coverage on Etteplan. Note that estimates and information have not been updated in this report, and will no longer...
Etteplan’s operative performance was good in Q3 although bottom-line figures were weaker than expected.
Q3 net sales were 3% above Refinitiv consensus. The company has not faced any remarkable demand weakness and expects Q4 2022 to be a solid q...
The company’s net sales was EUR 80.3m and 3% above market (Refinitiv) consensus in Q3.
Etteplan's net sales in Q3 amounted to EUR 80.3m, slightly above our and consensus estimates (EUR 78.
We revise our estimates due to the financial impact of the unsuccessful Semcon acquisition and accordingly lower our target price to EUR 15.
We remove Semcon's numbers from our estimates. Ratos offered 5.
Etteplan has made a EUR 253m cash offer to buy Swedish Semcon, a direct competitor.
Etteplan announced a recommended cash offer for Swedish technology company Semcon.
Etteplan offers SEK 149 per Semcon’s share, which is 32% over yesterdays’ close price.
Etteplan announced a recommended cash offer of SEK 149 per Semcon’s share, for a total value of approx.
Etteplan continued to post good growth figures in Q2, but profitability came in slightly soft.
Q2 EBITA was 7% below Refinitiv consensus due to lower utilisation rates and higher costs, but some of the cost pressure should be temporary...
Revenue growth was close to consensus (Refinitiv) but EBITA came 7% below consensus in Q2.
Etteplan's net sales in Q2 amounted to EUR 89.3m (EUR 88.
Etteplan saw strong growth and good profitability in Q1.
Etteplan is quite confident it can achieve healthy sales growth and stable margins for the rest of this year.
Regardless of geopolitical tensions and COVID-19 related sickness absences, Etteplan reported a good result in Q1.
Our concerns for a softer Q1 were clearly unfounded, as Etteplan's net sales grew 23% to EUR 89.
Etteplan reports Q1 results on May 5th. We remain on the cautious side due to the seen increase in sick leaves.
Q4 quite in line with expectations Etteplan reported Q4 results quite in line with expectations.
Etteplan's net sales in Q4 amounted to EUR 85.3m (EUR 82.
Etteplan reports Q4 results on February 10th, with expectations of rather good growth and margins.
Etteplan’s Q3 fell slightly short of our estimates.
Net sales in Q3 were 6% below Infront consensus while EBIT was 17% below.
Etteplan witnessed some demand weakness for engineering services begin of Q3.
Etteplan's net sales in Q3 amounted to EUR 66.9m, slightly below our estimates and below consensus (EUR 69.
Etteplan reports its Q3 results on October 28th. We expect to see solid growth figures on the weak comparison period and continued good prof...
Etteplan’s Q2 results were quite in line with expectations.
Etteplan has good visibility into H2 2021, but the key issue is how long the current upturn will last.
Etteplan's net sales in Q2 amounted to EUR 75.0m, in line with our and consensus estimates (EUR 73.
Etteplan reports Q2 results on August 11th and we expect notable improvement from the weak comparison period.
